These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 30241320)

  • 21. Immunisation Information Systems - useful tools for monitoring vaccination programmes in EU/EEA countries, 2016.
    Derrough T; Olsson K; Gianfredi V; Simondon F; Heijbel H; Danielsson N; Kramarz P; Pastore-Celentano L
    Euro Surveill; 2017 Apr; 22(17):. PubMed ID: 28488999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measles among migrants in the European Union and the European Economic Area.
    Williams GA; Bacci S; Shadwick R; Tillmann T; Rechel B; Noori T; Suk JE; Odone A; Ingleby JD; Mladovsky P; Mckee M
    Scand J Public Health; 2016 Feb; 44(1):6-13. PubMed ID: 26563254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of Screening and Treatment Approaches for Schistosomiasis and Strongyloidiasis in Newly-Arrived Migrants from Endemic Countries in the EU/EEA: A Systematic Review.
    Agbata EN; Morton RL; Bisoffi Z; Bottieau E; Greenaway C; Biggs BA; Montero N; Tran A; Rowbotham N; Arevalo-Rodriguez I; Myran DT; Noori T; Alonso-Coello P; Pottie K; Requena-Méndez A
    Int J Environ Res Public Health; 2018 Dec; 16(1):. PubMed ID: 30577567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention and assessment of infectious diseases among children and adult migrants arriving to the European Union/European Economic Association: a protocol for a suite of systematic reviews for public health and health systems.
    Pottie K; Mayhew AD; Morton RL; Greenaway C; Akl EA; Rahman P; Zenner D; Pareek M; Tugwell P; Welch V; Meerpohl J; Alonso-Coello P; Hui C; Biggs BA; Requena-Méndez A; Agbata E; Noori T; Schünemann HJ
    BMJ Open; 2017 Sep; 7(9):e014608. PubMed ID: 28893741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reducing burden from respiratory infections in refugees and immigrants: a systematic review of interventions in OECD, EU, EEA and EU-applicant countries.
    Lambert JF; Stete K; Balmford J; Bockey A; Kern W; Rieg S; Boeker M; Lange B
    BMC Infect Dis; 2021 Aug; 21(1):872. PubMed ID: 34445957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries.
    Madeddu G; Vroling H; Oordt-Speets A; Babudieri S; O'Moore É; Noordegraaf MV; Monarca R; Lopalco PL; Hedrich D; Tavoschi L
    Vaccine; 2019 Aug; 37(35):4906-4919. PubMed ID: 31327651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restricted health care entitlements for child migrants in Europe and Australia.
    Stubbe Østergaard L; Norredam M; Mock-Munoz de Luna C; Blair M; Goldfeld S; Hjern A
    Eur J Public Health; 2017 Oct; 27(5):869-873. PubMed ID: 28633364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interventions to reduce the burden of vaccine-preventable diseases among migrants and refugees worldwide: A scoping review of published literature, 2006-2018.
    Charania NA; Gaze N; Kung JY; Brooks S
    Vaccine; 2020 Oct; 38(46):7217-7225. PubMed ID: 33008670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Migration-related tuberculosis: epidemiology and characteristics of tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013.
    Ködmön C; Zucs P; van der Werf MJ
    Euro Surveill; 2016; 21(12):. PubMed ID: 27039665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination campaign strategies in recently arrived migrants: experience of an Italian reception centre.
    Vita S; Sinopoli MT; Fontanelli Sulekova L; Morucci L; Lopalco M; Spaziante M; Pacifici LE; Bazzardi R; Angeletti S; Ciccozzi M; Ceccarelli G
    J Infect Dev Ctries; 2019 Dec; 13(12):1159-1164. PubMed ID: 32088704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic Review.
    Greenaway C; Makarenko I; Chakra CNA; Alabdulkarim B; Christensen R; Palayew A; Tran A; Staub L; Pareek M; Meerpohl JJ; Noori T; Veldhuijzen I; Pottie K; Castelli F; Morton RL
    Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30223539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review.
    Wong CKH; Liao Q; Guo VYW; Xin Y; Lam CLK
    Vaccine; 2017 May; 35(24):3153-3161. PubMed ID: 28476628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restricted access to antiretroviral treatment for undocumented migrants: a bottle neck to control the HIV epidemic in the EU/EEA.
    Deblonde J; Sasse A; Del Amo J; Burns F; Delpech V; Cowan S; Levoy M; Keith L; Pharris A; Amato-Gauci A; Noori T
    BMC Public Health; 2015 Dec; 15():1228. PubMed ID: 26654427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of hepatitis B vaccination behavior and vaccination willingness among migrant workers from rural China based on protection motivation theory.
    Liu R; Li Y; Wangen KR; Maitland E; Nicholas S; Wang J
    Hum Vaccin Immunother; 2016 May; 12(5):1155-63. PubMed ID: 27078191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for infectious diseases among newly arrived migrants in EU/EEA countries--varying practices but consensus on the utility of screening.
    Kärki T; Napoli C; Riccardo F; Fabiani M; Dente MG; Carballo M; Noori T; Declich S
    Int J Environ Res Public Health; 2014 Oct; 11(10):11004-14. PubMed ID: 25337945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vaccination Uptake in Newly-Arrived Migrants in France].
    Vignier N; Moussaoui S
    Bull Soc Pathol Exot; 2020; 113(1):42-51. PubMed ID: 32881441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020.
    Margineanu I; Rustage K; Noori T; Zenner D; Greenaway C; Pareek M; Akkerman O; Hayward S; Friedland JS; Goletti D; Stienstra Y; Hargreaves S;
    Euro Surveill; 2022 Mar; 27(12):. PubMed ID: 35332865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis among migrant populations in the European Union and the European Economic Area.
    Odone A; Tillmann T; Sandgren A; Williams G; Rechel B; Ingleby D; Noori T; Mladovsky P; McKee M
    Eur J Public Health; 2015 Jun; 25(3):506-12. PubMed ID: 25500265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What are the challenges in the vaccination of migrants in Norway from healthcare provider perspectives? A qualitative, phenomenological study.
    Socha A; Klein J
    BMJ Open; 2020 Nov; 10(11):e040974. PubMed ID: 33234649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil.
    Sartori AMC; de Soárez PC; Fernandes EG; Gryninger LCF; Viscondi JYK; Novaes HMD
    Vaccine; 2016 Mar; 34(13):1531-1539. PubMed ID: 26899375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.